Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biophotonics Discovery is Scopus-indexed (Q3, CiteScore 1.4). It is covered by India's One Nation One Subscription scheme for reading access. Published by SPIE.
Checked against the index lists dated .
ISSN 3005-4745Verify ISSN ↗
Publisher: SPIE
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 286 / 466 | 38th | Q3 |
| Artificial Intelligence | 383 / 570 | 32nd | Q3 |
| Radiology, Nuclear Medicine and Imaging | 255 / 361 | 29th | Q3 |
| Biochemistry, Genetics and Molecular Biology (all) | 167 / 223 | 25th | Q3 |
| Biomedical Engineering | 280 / 342 | 18th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q3, CiteScore 1.4.
Biophotonics Discovery is Q3 in Medicine (miscellaneous) (rank 286 of 466), Q3 in Artificial Intelligence (rank 383 of 570) and Q3 in Radiology, Nuclear Medicine and Imaging (rank 255 of 361), by CiteScore 2025. It is ranked in 5 subject areas in all.
Biophotonics Discovery is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.4, quartile Q3, 38th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.278, quartile Q3, with an H-index of 4.
Biophotonics Discovery is published by SPIE. Its ISSN is 3005-4745.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biophotonics Discovery has an h-index of 6 and a 2-year mean of 1.42 citations per paper (OpenAlex). Its Scopus CiteScore is 1.4, quartile Q3. On 2-year citations it ranks #217 of 451 Scopus journals in Medicine (miscellaneous).
Biophotonics Discovery published 36 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 82 research articles (2024–2026), authors are most often from United States (76%), Canada (6.7%) and Netherlands (5.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.